Home
Market Watch
Portfolio Manager
Top
Highlights:

Charting TechnicalChart
  KLSE Market Watch
Volume
Change
Ref
Open
High
Low

Share Price on 28 Apr 2017

* Price is 15 minutes delay.

Market Capital (RM)
Number of Share
EPS (cent)
P/E Ratio
ROE (%)
Dividend (cent)
Dividend Yield (%)
Dividend Policy (%)
NTA (RM)
Par Value (RM)

* Calculated based on the net profit of the trailing twelve months and latest number of shares issued.

DateFinancial
Year
No. Financial
Quarter
Revenue
(RM,000)
PBT (RM,000)Net Profit
(RM,000)
EPS (Cent)Dividend
(Cent)
NTA
(RM)
Download
Report
28 Mar 201731 Oct 2017131 Jan 20179,381391910.130.000.530 Malaysia Stock - KLSE Quarter Report History
27 Dec 201631 Oct 2016431 Oct 201610,5688001410.090.000.530 Malaysia Stock - KLSE Quarter Report History
29 Sep 201631 Oct 2016331 Jul 20167,677-105-455-0.300.000.530 Malaysia Stock - KLSE Quarter Report History
28 Jun 201631 Oct 2016230 Apr 20169,383346470.030.000.530 Malaysia Stock - KLSE Quarter Report History
29 Mar 201631 Oct 2016131 Jan 201612,3031,3589380.610.000.530 Malaysia Stock - KLSE Quarter Report History
18 Dec 201531 Oct 2015431 Oct 201510,0471,1297560.490.000.530 Malaysia Stock - KLSE Quarter Report History
22 Sep 201531 Oct 2015331 Jul 20159,4371,2288170.530.000.520 Malaysia Stock - KLSE Quarter Report History
23 Jun 201531 Oct 2015230 Apr 201511,2381,2057420.490.000.520 Malaysia Stock - KLSE Quarter Report History
17 Mar 201531 Oct 2015131 Jan 201511,1591,4387740.510.000.510 Malaysia Stock - KLSE Quarter Report History
23 Dec 201431 Oct 2014431 Oct 201411,7002,0251,1670.760.000.510 Malaysia Stock - KLSE Quarter Report History
25 Sep 201431 Oct 2014331 Jul 201410,0911,9501,3610.890.000.500 Malaysia Stock - KLSE Quarter Report History
25 Jun 201431 Oct 2014230 Apr 20145,9018293990.260.000.490 Malaysia Stock - KLSE Quarter Report History
1234

DateFinancial
Year
Ex-DateEntitlement
Date
Payment
Date
Entitlement TypeDividend
(Cent)
Dividend
(%)
Details
20 Dec 201231 Oct 201204 Jan 201308 Jan 201321 Jan 2013Others170.00000.00 Malaysia Stock -  Dividend
05 Apr 201131 Oct 201028 Jun 201130 Jun 201118 Jul 2011First and Final Dividend7.00000.00 Malaysia Stock -  Dividend
02 Mar 201031 Oct 200923 Mar 201025 Mar 201020 Apr 2010Final Dividend4.00000.00 Malaysia Stock -  Dividend
25 May 200931 Oct 200908 Jun 200910 Jun 200925 Jun 2009Interim Dividend3.00000.00 Malaysia Stock -  Dividend
03 Jun 200831 Jan 200807 Jul 200809 Jul 200825 Jul 2008Final Dividend4.40000.00 Malaysia Stock -  Dividend
04 Jun 200731 Jan 200710 Jul 200712 Jul 200726 Jul 2007Final Dividend0.00006.00 Malaysia Stock -  Dividend
08 May 200631 Jan 200602 Jun 200606 Jun 200620 Jun 2006Final Dividend0.00007.00 Malaysia Stock -  Dividend
05 Jul 200531 Jan 200529 Jul 200502 Aug 200522 Aug 2005Final Dividend0.00003.00 Malaysia Stock -  Dividend
27 Sep 200431 Jan 200517 Nov 200419 Nov 200403 Dec 2004Interim Dividend0.00003.00 Malaysia Stock -  Dividend

DateEx-DateEntitlement
Date
Transfer
Date
TypeRatioRight Issue
Price
Details
01 Jun 200619 Jun 200621 Jun 200621 Jun 2006Bonus Issue2 : 50.000 Malaysia Stock -  Bonus/Rights Issue
01 Jun 200619 Jun 200621 Jun 200621 Jun 2006Others1 : 50.000 Malaysia Stock -  Bonus/Rights Issue

ADVENTA (7191) : ADVENTA BERHAD
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
08 Oct 2012, 10:03 AMPost #21
Today another company for sales is 7064 (latexx) because they knew that this for long run is not good , this case like adventa not small and not big in between. However rising production cost like labour and rubber also forex exchange for dollar down trend this key factor.
juwelung
Member Star
Posts: 3
Joined: Dec 2012
Male, MYS
26 Dec 2012, 09:18 PMPost #22
is the company going to bankrupt?
Jusoh
Member Star
Posts: 9
Joined: Oct 2012
Male, MYS
04 Jan 2013, 06:57 PMPost #23
is the company going to bankrupt?juwelung @ 26 Dec 2012, 09:18 PM
Fair Value : RM2.00 | Recom : Market Perform (Cease Coverage)

Above expectations. Adventa’s 4QFY10/12 net profit of RM11.5m (+>100% yoy; +>100% qoq), was above our and consensus expectations with full-year FY12 net profit of RM25.5m (+93.8% yoy) accounting for 133% and 129% of our and consensus full-year net profit estimates respectively. Key variance was higher-than-expected EBIT margin of 7.4% vs. our full-year EBIT margin forecast of 6.8% as we had underestimated Adventa’s ability to retain savings arising from the lower latex prices. As expected, no dividend was declared during the quarter.

4Q earnings doubled qoq. Qoq, revenue was 10.2% higher thanks to a rapid ramp-up in nitrile glove production from seven new lines at the Johor plant. We believe this was partly offset by weaker US$ rate of RM3.08/US$ (3Q: RM3.15/US) and marginally lower ASPs to pass on the lower latex cost (-12.5% qoq). 4Q EBIT margin, however, saw a significant expansion of 4%-pts qoq thanks to the timelag in passing on the lower average latex price of RM5.94/kg (vs. RM6.79/kg in 3Q). Coupled with a tax writeback of RM0.8m for the quarter (vs. tax charge of RM0.2m in 3Q), 4Q net profit came in significantly higher at RM11.5m (vs. RM5.2m in 3Q).

Risks. The risks include: 1) sharp decline in latex price, which may result in margin expansion; and 2) a weaker RM against the US$.

Forecasts. We have increased our FY13-14 earnings forecasts by 18.6- 21.2%, after raising our FY13-14 nitrile glove ASP by 3% p.a.. Our numbers currently do not reflect the disposal of Adventa’s glove business as pending the completion of Adventa’s acquisition of Electron Beam for RM9m and the distribution of the amount equivalent to RM260m, Adventa remains largely a cash company.

Investment case. No change to our fair value of RM2.00, which is based on a 5% discount to Aspion’s takeover offer. Following the completion of Aspion’s purchase of Adventa on 30 Nov, Adventa had announced that the share will go ex- for the distribution of an amount equivalent to RM1.70/share on 4 Jan (payment on 21 Jan). We note that post-disposal, Adventa intends to maintain its listing status and would thus utilise the remaining RM61.1m to reinvent itself as an intergrated healthcare player with a focus on distribution of medical products, sterilisation services and peretonial dialysis home-treatment services. While Adventa’s peretonial dialysis business appears promising over the longer term, we note that the project is currently at a greenfield stage and thus bears a high execution risk. With the completion of the disposal of its glove business, we are ceasing coverage on the stock.

Source: RHB Research - 03 Jan 2013
From www.i3investor.com
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
04 Jan 2013, 10:10 PMPost #24
ahya this can go like today after ex. very good perform right because their business as long in healthcare is good.
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
07 Jan 2013, 10:05 AMPost #25
Yeh the horse still running all theway yes yes thumbupdroolyeahlol
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
07 Jan 2013, 10:59 AMPost #26
is the company going to bankrupt?juwelung @ 26 Dec 2012, 09:18 PM
Nah bankrupt , now running like horse yes yes thumbupyeahdrool
juwelung
Member Star
Posts: 3
Joined: Dec 2012
Male, MYS
09 Jan 2013, 11:48 AMPost #27

Nah bankrupt , now running like horse yes yes ...wow123 @ 07 Jan 2013, 10:59 AM

Nah running like horse, now PN17 alreadyrolleyes
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
10 Jan 2013, 11:31 AMPost #28

Nah running like horse, now PN17 already...juwelung @ 09 Jan 2013, 11:48 AM

please lah they have 12 month to submit their regulation plan.
weathhunter
Member Star
Posts: 1
Joined: Apr 2013
Male, MYS
05 Apr 2013, 11:39 AMPost #29
itz this share is still good for hold at long run questionquestion
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
07 Aug 2013, 08:55 AMPost #30
itz this share is still good for hold at long run ...weathhunter @ 05 Apr 2013, 11:39 AM

According medical device business are very high profit due many have common cancer like NPC 1 ratio 4 man 1 NPC among chinese , kidney etc. In penang private hospital , GMC , Aventist , Loh guan lye , Island & pantai , tanjong , Mount miriam cancer many visitor from around the world every years. For long run is good. In penang is best cancer treatment in malaysia because they tomohd latest generation gadget.
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
24 Sep 2013, 03:30 PMPost #31
adventa is back yes yes up up
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
25 Sep 2013, 11:31 AMPost #32
this having great day , moving forward
ILoveDividend
Member Star
Posts: 499
Joined: Dec 2011
Male, MYS
25 Sep 2013, 11:38 AMPost #33
this having great day , moving forward wow123 @ 25 Sep 2013, 11:31 AM

Any good news?
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
26 Sep 2013, 10:38 AMPost #34
still a head and great day moving forward.
jeloft
Member Star
Posts: 17
Joined: Mar 2012
Male, MYS
28 Sep 2013, 05:04 PMPost #35
Still a PN17 company!?
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
07 Oct 2013, 01:07 PMPost #36
still a head today , as long they turn around good business that is good.
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
17 Dec 2013, 05:32 PMPost #37
According this counter still a head RM1 mark in 3 month after paying RM1,700.00 / share. That mean after ex. is around RM0,290 sen but today RM1,150. Horse still running.
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
02 Jan 2014, 07:10 PMPost #38
On tuesday 31.12.2013 they already submitted lifted PN17 , if sucessful will be not that prices for this share. For now at least RM2.00, The company get green light from bursa. Let see in one month !
wow123
Member Star
Posts: 98
Joined: Jun 2012
Male, HKG
20 Feb 2014, 07:31 PMPost #39
Kindly be advised that ADVENTA will be uplifted from being classified as a PN17 company effective 9.00 a.m. on 21 February 2014. For further details, kindly refer to the Company's announcement dated 20 February 2014.

yeah doh drool lol mad notworthy question rant rolleyes sad shutup shy smile star sweat thumbup wub cry

Close